Cas:23643-29-0 [(1R,2S,3R,4R,5R)-3,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate manufacturer & supplier

Chemical Name:[(1R,2S,3R,4R,5R)-3,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate

CAS.NO:23643-29-0

Synonyms:Levoglucosan 4-p-Toluenesulfonate;1,6-Anhydro-4-O-p-toluenesulfonyl-|A-D-glucopyranose

Molecular Formula:C₁₃H₁₆O₇S

Molecular Weight:316.32700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:547.931ºC at 760 mmHg

Density:1.557g/cm3

Index of Refraction:1.628

PSA:110.67000

Exact Mass:316.06200

LogP:0.62660

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Levoglucosan 4-p-Toluenesulfonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,6-Anhydro-4-O-p-toluenesulfonyl-|A-D-glucopyranose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,6-Anhydro-4-O-p-toluenesulfonyl-|A-D-glucopyranose Use and application,Levoglucosan 4-p-Toluenesulfonate technical grade,usp/ep/jp grade.

Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. [(1R,2S,3R,4R,5R)-3,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate manufacturer The fine and functional chemicals sector provides new growth drivers. [(1R,2S,3R,4R,5R)-3,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate supplier The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions. [(1R,2S,3R,4R,5R)-3,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate vendor In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. [(1R,2S,3R,4R,5R)-3,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate factory In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available.